Lanean...

Phase II Cancer Prevention Clinical Trials

The development of agents to prevent cancer requires an iterative process of target identification, preclinical testing, and early and late phase clinical trials to establish efficacy and safety. Since phase III definitive efficacy trials with cancer endpoints require a lengthy timeframe and conside...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Szabo, Eva
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935910/
https://ncbi.nlm.nih.gov/pubmed/20816506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2010.06.015
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!